News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Denied: Federal Judge Grants Amarin (AMRN) Permission to Promote Fish Oil Drug



8/10/2015 7:02:57 AM

A Federal judge in New York today granted Amarin Pharma’s request for an injunction against the enforcement by the U.S. Food & Drug Administration of rules that would otherwise prohibit the communication to physicians of truthful information about unapproved uses of its product Vascepa® (isocapent ethyl).

Today’s ruling follows the 2012 opinion by the U.S. 2nd Circuit Court of Appeals in United States v. Caronia that tossed out a misbranding conviction on the basis of the promotion of Jazz Pharmaceutical’s drug Xyrem® (sodium oxybate) by a sales representative for conveying truthful and non-misleading information to doctors.

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes
Read at Wall Street Journal
Read at Washington Post


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES